Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tony Gibson

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical & Experimental Optometry|February 16, 2016
Optometry's role in managing patients with glaucomaTony Gibson
Journal of Medicinal Chemistry|January 9, 2010
Fructose-1,6-bisphosphatase Inhibitors. 2. Design, synthesis, and structure-activity relationship of a series of phosphonic acid containing benzimidazoles that function as 5'-adenosinemonophosphate (AMP) mimicsQun Dang, Srinivas Rao Kasibhatla, Wei Xiao, et al.
Journal of Medicinal Chemistry|December 4, 2010
Discovery of a series of phosphonic acid-containing thiazoles and orally bioavailable diamide prodrugs that lower glucose in diabetic animals through inhibition of fructose-1,6-bisphosphataseQun Dang, Yan Liu, Daniel K Cashion, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart FailureMarion Lanier, Jason Pickens, Simone V Bigi, et al.
ACS Medicinal Chemistry Letters|December 21, 2017
Correction to "Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart Failure"Marion Lanier, Jason Pickens, Simone V Bigi, et al.
Gut|February 23, 2025
Characterisation of MRGPRX2<sup>+</sup> mast cells in irritable bowel syndromeLisse Decraecker, María Cuende Estévez, Samuel Van Remoortel, et al.
Journal of Medicinal Chemistry|October 17, 2017
Hit-to-Lead Optimization and Discovery of 5-((5-([1,1'-Biphenyl]-4-yl)-6-chloro-1H-benzo[d]imidazol-2-yl)oxy)-2-methylbenzoic Acid (MK-3903): A Novel Class of Benzimidazole-Based Activators of AMP-Activated Protein KinasePing Lan, F Anthony Romero, Dariusz Wodka, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical & Experimental Optometry|February 16, 2016
Optometry's role in managing patients with glaucomaTony Gibson
Journal of Medicinal Chemistry|January 9, 2010
Fructose-1,6-bisphosphatase Inhibitors. 2. Design, synthesis, and structure-activity relationship of a series of phosphonic acid containing benzimidazoles that function as 5'-adenosinemonophosphate (AMP) mimicsQun Dang, Srinivas Rao Kasibhatla, Wei Xiao, et al.
Journal of Medicinal Chemistry|December 4, 2010
Discovery of a series of phosphonic acid-containing thiazoles and orally bioavailable diamide prodrugs that lower glucose in diabetic animals through inhibition of fructose-1,6-bisphosphataseQun Dang, Yan Liu, Daniel K Cashion, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart FailureMarion Lanier, Jason Pickens, Simone V Bigi, et al.
ACS Medicinal Chemistry Letters|December 21, 2017
Correction to "Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart Failure"Marion Lanier, Jason Pickens, Simone V Bigi, et al.
Gut|February 23, 2025
Characterisation of MRGPRX2<sup>+</sup> mast cells in irritable bowel syndromeLisse Decraecker, María Cuende Estévez, Samuel Van Remoortel, et al.
Journal of Medicinal Chemistry|October 17, 2017
Hit-to-Lead Optimization and Discovery of 5-((5-([1,1'-Biphenyl]-4-yl)-6-chloro-1H-benzo[d]imidazol-2-yl)oxy)-2-methylbenzoic Acid (MK-3903): A Novel Class of Benzimidazole-Based Activators of AMP-Activated Protein KinasePing Lan, F Anthony Romero, Dariusz Wodka, et al.
Pageof 1